About
Amber Implants BV is a Dutch med-tech company founded in 2019, specializing in innovative spinal implant solutions. The company was established by Dr. Banafsheh Sajadi and Dr. Mohammad Ahmadi, both Ph.D. graduates from Delft University of Technology. Amber Implants focuses on addressing unmet clinical needs in spinal care, particularly for patients suffering from vertebral fractures. The flagship product, the VCFix® Spinal System, is designed for treating vertebral compression fractures and other spinal injuries. This next-generation implant system aims to provide a safer and more effective alternative to existing treatments, which often have high rates of side effects. Amber Implants adheres to strict regulatory standards, including ISO 13485 and FDA guidelines, ensuring high-quality manufacturing of its medical devices. The company has completed pre-clinical validation of the VCFix® system and has initiated clinical trials in 2023. Amber Implants is supported by venture capital and collaborates with various European and national research partners to advance spinal implant technology. The team consists of a mix of young professionals and experienced experts, all dedicated to improving the quality of life for patients with spinal disorders.
Technologies
Keywords
Company Information
-
Employees 17
-
Founded 2018
-
Total Funding $10000000
Location
546 Prinses Beatrixlaan, Den Haag, Zuid-Holland, Netherlands, 2595 BM